Get started
Author

Ming‐Wen An

Subjective and Objective Sleep Quality and Aging in the Sleep Heart Health Study
2008 · Mark L. Unruh, Susan Redline, et al. · Journal of the American Geriatrics Society · 271
Longitudinal Evaluation of Sleep-Disordered Breathing and Sleep Symptoms with Change in Quality of Life: The Sleep Heart Health Study (SHHS)
2009 · Graciela E. Silva, Ming-Wen An, et al. · SLEEP · 91
PDF
Clinical trial designs incorporating predictive biomarkers
2016 · Lindsay A. Renfro, Himel Mallick, et al. · Cancer Treatment Reviews · 84
Sampling-Based Approaches to Improve Estimation of Mortality among Patient Dropouts: Experience from a Large PEPFAR-Funded Program in Western Kenya
2008 · Constantin T. Yiannoutsos, Ming-Wen An, et al. · PLoS ONE · 78
PDF
Precision oncology: A new era of cancer clinical trials
2016 · Lindsay A. Renfro, Ming-Wen An, et al. · Cancer Letters · 75
Differential Gene Expression of TGFβ Inducible Early Gene (TIEG), Smad7, Smad2 and Bard1 in Normal and Malignant Breast Tissue
2004 · Monica M. Reinholz, Ming-Wen An, et al. · Breast Cancer Research and Treatment · 55
Principal Stratification Designs to Estimate Input Data Missing Due to Death
2007 · Constantine E. Frangakis, Donald B. Rubin, et al. · Biometrics · 50
Evaluation of Alternate Categorical Tumor Metrics and Cut Points for Response Categorization Using the RECIST 1.1 Data Warehouse
2014 · Sumithra J. Mandrekar, Ming-Wen An, et al. · Journal of Clinical Oncology · 45
Comparison of Continuous versus Categorical Tumor Measurement–Based Metrics to Predict Overall Survival in Cancer Treatment Trials
2011 · Ming-Wen An, Sumithra J. Mandrekar, et al. · Clinical Cancer Research · 35
PDF
Evaluation of the Optimal Number of Lesions Needed for Tumor Evaluation Using the Response Evaluation Criteria in Solid Tumors: A North Central Cancer Treatment Group Investigation
2009 · Shauna L. Hillman, Ming-Wen An, et al. · Journal of Clinical Oncology · 35
PDF
Flexible random intercept models for binary outcomes using mixtures of normals
2006 · Brian Caffo, Ming-Wen An, et al. · Computational Statistics & Data Analysis · 32
Evaluation of School-Based Smoking-Cessation Interventions for Self-Described Adolescent Smokers
2009 · Alain Joffe, Clea McNeely, et al. · PEDIATRICS · 29
Regional and temporal variation in American Red Cross blood donations, 1995 to 2005
2008 · Stephen O. Crawford, Nicholas G. Reich, et al. · Transfusion · 26
Principles of Good Clinical Trial Design
2020 · Ming-Wen An, Quyen Duong, et al. · Journal of Thoracic Oncology · 25
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival
2015 · Ming-Wen An, Xinxin Dong, et al. · JNCI Journal of the National Cancer Institute · 25
PDF
Test on existence of histology subtype-specific prognostic signatures among early stage lung adenocarcinoma and squamous cell carcinoma patients using a Cox-model based filter
2015 · Suyan Tian, Chi Wang, et al. · Biology Direct · 25
PDF
The Need for Double‐Sampling Designs in Survival Studies: An Application to Monitor PEPFAR
2008 · Ming‐Wen An, Constantine E. Frangakis, et al. · Biometrics · 25
PDF
Reopening Colleges During the Coronavirus Disease 2019 (COVID-19) Pandemic—One Size Does Not Fit All
2020 · Elizabeth H. Bradley, Ming-Wen An, et al. · JAMA Network Open · 23
PDF
A review of phase II trial designs for initial marker validation
2013 · Sumithra J. Mandrekar, Ming-Wen An, et al. · Contemporary Clinical Trials · 23
A 2-Stage Phase II Design with Direct Assignment Option in Stage II for Initial Marker Validation
2012 · Ming-Wen An, Sumithra J. Mandrekar, et al. · Clinical Cancer Research · 14
A Stochastic Simulator of a Blood Product Donation Environment with Demand Spikes and Supply Shocks
2011 · Ming-Wen An, Nicholas G. Reich, et al. · PLoS ONE · 10
PDF
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods
2015 · Ming-Wen An, Yu Han, et al. · Journal of Clinical Oncology · 7
PDF
Missing tumor measurement (TM) data in the search for alternative TM-based endpoints in cancer clinical trials
2019 · Ming-Wen An, Jun Tang, et al. · Contemporary Clinical Trials Communications · 5
PDF
Application of Tumor Measurement–Based Metrics in the Real World
2013 · Ming-Wen An, Sumithra J. Mandrekar, et al. · Journal of Clinical Oncology · 5
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies
2019 · Fang-Shu Ou, Ming-Wen An, et al. · JCO Precision Oncology · 4
Works count: 50
Citation count: 1,117
H-index: 19
I10-index: 21
Year
Topic
Type